证券记录 · 已归档季度
VOR
Vor Biopharma Inc. · Healthcare · Biotechnology
31被追踪持有人
+7Δ持有人
8.52M持有股份
$152.06M报告持仓市值
+8新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +29.2% ·
股份流向 +30.0% ·
净新建仓位 +20.0%
· 公式
广泛增持：持股数量上升，持有人数量增加
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q1 2026
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 46 | +15 | 17.25M | $317.51M | +16 | −1 |
| Q1 2026 | 31 | +7 | 8.52M | $152.06M | +8 | −1 |
| Q4 2025 | 24 | -1 | 5.67M | $74.16M | n/a | −1 |
| Q3 2025 | 11 | +1 | 478.12K | $23.29M | +2 | −1 |
| Q2 2025 | 7 | -2 | 5.57M | $9.03M | n/a | −2 |
| Q1 2025 | 6 | -1 | 1.58M | $1.14M | n/a | −1 |
| Q4 2024 | 7 | 0 | 1.73M | $1.92M | n/a | n/a |
| Q3 2024 | 6 | 0 | 1.74M | $1.22M | +1 | −1 |
| Q2 2024 | 6 | n/a | 1.49M | $1.49M | n/a | n/a |
持有人 · Q1 2026
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 1.54M | -39.0% | $27.47M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 2 | Vanguard Capital Management Llc | 1.43M | n/a | $25.57M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Marshall Wace ✦ | 1.15M | 新增 | $20.57M | 0.0% | New | 1 | SEC ↗ ×3 |
| 4 | State Street Global Advisors ✦ (被动) | 1.12M | +1128.4% | $19.95M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 794.76K | +70.7% | $14.18M | 0.0% | ▲ Add | 4 | SEC ↗ ×9 |
| 6 | UBS Group AG | 488.37K | +67.2% | $8.71M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 7 | Geode Capital Management ✦ (被动) | 342.57K | +84.4% | $6.11M | 0.0% | ▲ Add | 8 | SEC ↗ ×2 |
| 8 | Goldman Sachs Group ✦ | 261.89K | +79.8% | $4.67M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Millennium Management ✦ | 258.59K | +15.2% | $4.61M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Susquehanna International Group, Llp | 232.61K | +1469.7% | $4.15M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Tudor Investment Corp Et Al | 152.57K | -9.0% | $2.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 148.77K | -65.7% | $2.65M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 128.84K | 新增 | $2.30M | 0.0% | New | 1 | SEC ↗ |
| 14 | Morgan Stanley ✦ | 116.72K | +310.1% | $2.08M | 0.0% | ▲ Add | 3 | SEC ↗ ×6 |
| 15 | Bank Of America Corp /De/ | 112.89K | +28408.1% | $2.01M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 16 | Jane Street Group, Llc | 75.89K | -17.3% | $1.35M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 17 | Northern Trust Corp | 64.55K | +65.7% | $1.15M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | Squarepoint Ops LLC | 25.48K | +38.0% | $454,599 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | Charles Schwab Investment… | 22.22K | 新增 | $396,333 | 0.0% | New | 1 | SEC ↗ |
| 20 | Sei Investments Co | 13.72K | 新增 | $244,529 | 0.0% | New | 1 | SEC ↗ ×2 |
| 21 | Invesco Ltd. | 11.60K | 新增 | $206,944 | 0.0% | New | 1 | SEC ↗ |
| 22 | Group One Trading Llc | 9.06K | 新增 | $161,720 | 0.0% | New | 1 | SEC ↗ |
| 23 | Citigroup Inc | 5.37K | -15.2% | $95,854 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 24 | JPMorgan Chase ✦ | 4.36K | +88.8% | $64,151 | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 25 | MIRAE ASSET GLOBAL ETFS HOLDINGS… | 3.51K | 新增 | $51,641 | 0.0% | New | 1 | SEC ↗ |
| 26 | Bnp Paribas Financial Markets | 2.84K | +877.3% | $50,737 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 27 | Mirae Asset Global Investments Co.… | 2.17K | +164.5% | $38,641 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 28 | Pnc Financial Services Group, Inc. | 246 | 新增 | $4,389 | 0.0% | New | 1 | SEC ↗ ×3 |
| 29 | Royal Bank Of Canada | 199 | +2742.9% | $4,000 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 30 | Barclays Plc | 136 | -90.3% | $2,426 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 31 | Wells Fargo & Company/Mn | 1 | 0.0% | $18 | 0.0% | Held | 2 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Marshall Wace | $20.57M | 0.0% |
| Renaissance Technologies | $2.30M | 0.0% |
| Charles Schwab Investment… | $396,333 | 0.0% |
| Sei Investments Co | $244,529 | 0.0% |
| Invesco Ltd. | $206,944 | 0.0% |
| Group One Trading Llc | $161,720 | 0.0% |
| MIRAE ASSET GLOBAL ETFS… | $51,641 | 0.0% |
| Pnc Financial Services Group… | $4,389 | 0.0% |
已清仓
| Ameriprise Financial Inc | $2.13M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 79 持有人, 40.44M 股份, $716.36M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
Aug 14
SC 13G/A: Venrock Healthcare Capital Partners…
Aug 14
SC 13G/A: Frazier Life Sciences Public Fund, L.P.
Aug 13
SC 13G/A: Verve Capital Ltd
Aug 07
SC 13G/A: FMR LLC
Aug 06
SC 13G: FMR LLC
Jul 30
SC 13G: BlackRock, Inc.
Jul 21
SC 13D/A: RA CAPITAL MANAGEMENT, L.P.
19.9% 占股份类别 · 查看 SEC 原始申报文件 ↗
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q1 2026 ·
方法论 ·
通过API获取此数据